Literature DB >> 18803656

Promotion of incisional wound repair by human mesenchymal stem cell transplantation.

Alexander Stoff1, Angel A Rivera, N Sanjib Banerjee, Steven T Moore, T Michael Numnum, Antonio Espinosa-de-Los-Monteros, Dirk F Richter, Gene P Siegal, Louise T Chow, Dale Feldman, Luis O Vasconez, J Michael Mathis, Mariam A Stoff-Khalili, David T Curiel.   

Abstract

The purpose of this study was to determine the effect of transplanted human mesenchymal stem cells (hMSCs) on wound healing. In this model, full-thickness cutaneous wounds were created by incision in the skin of adult New Zealand white rabbits and treated by transplanted hMSCs into the wounds. Wound healing was evaluated by histological analysis and tensiometry over time. A total of 15 New Zealand white rabbits with 10 wounds per animal were examined in this study. Animals were treated with hMSCs and euthanised at 3, 7, 14, 21 and 80 days after manipulation. The hMSCs were labelled with a fluorescent dye (CM-DiI), suspended in phosphate-buffered saline and used to treat full-thickness incisional wounds in rabbit skin. Tensiometry and histology were used to characterise the wound-healing rate of the incisional wounds. These results showed that transplanted hMSCs significantly inhibited scar formation and increased the tensile strength of the wounds. Importantly, MSCs from genetically unrelated donors did not appear to induce an immunologic response. In conclusion, human mesenchymal stem cell therapy is a viable approach to significantly affect the course of normal cutaneous wound healing and significantly increase the tensile strength.

Entities:  

Mesh:

Year:  2008        PMID: 18803656      PMCID: PMC2664391          DOI: 10.1111/j.1600-0625.2008.00792.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  32 in total

1.  Development of a histomorphologic scale to quantify cutaneous scars after burns.

Authors:  A J Singer; H C Thode; S A McClain
Journal:  Acad Emerg Med       Date:  2000-10       Impact factor: 3.451

2.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

3.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

4.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

Authors:  Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo D Longoni; Paola Matteucci; Salvatore Grisanti; Alessandro M Gianni
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

5.  Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries.

Authors:  E Mansilla; G H Marin; F Sturla; H E Drago; M A Gil; E Salas; M C Gardiner; G Piccinelli; S Bossi; E Salas; L Petrelli; G Iorio; C A Ramos; C Soratti
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

6.  Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality.

Authors:  Ichiro Sekiya; Benjamin L Larson; Jason R Smith; Radhika Pochampally; Jian-Guo Cui; Darwin J Prockop
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

7.  Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells.

Authors:  Yang D Teng; Erin B Lavik; Xianlu Qu; Kook I Park; Jitka Ourednik; David Zurakowski; Robert Langer; Evan Y Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

8.  Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing.

Authors:  K W Liechty; M Nesbit; M Herlyn; A Radu; N S Adzick; T M Crombleholme
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

9.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

10.  Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord.

Authors:  Mark W Ronsyn; Jasmijn Daans; Gie Spaepen; Shyama Chatterjee; Katrien Vermeulen; Patrick D'Haese; Viggo Fi Van Tendeloo; Eric Van Marck; Dirk Ysebaert; Zwi N Berneman; Philippe G Jorens; Peter Ponsaerts
Journal:  BMC Biotechnol       Date:  2007-12-14       Impact factor: 2.563

View more
  38 in total

Review 1.  Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair.

Authors:  Anne M Hocking; Nicole S Gibran
Journal:  Exp Cell Res       Date:  2010-05-13       Impact factor: 3.905

Review 2.  Cell therapy of burns.

Authors:  T Leclerc; C Thepenier; P Jault; E Bey; J Peltzer; M Trouillas; P Duhamel; L Bargues; M Prat; M Bonderriter; J-J Lataillade
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 3.  [Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications].

Authors:  K Sellheyer; D Krahl
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

Review 4.  Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

5.  Elastin-based biomaterials and mesenchymal stem cells.

Authors:  Jazmin Ozsvar; Suzanne M Mithieux; Richard Wang; Anthony S Weiss
Journal:  Biomater Sci       Date:  2015-06       Impact factor: 6.843

6.  Implantation of placenta-derived mesenchymal stem cells accelerates murine dermal wound closure through immunomodulation.

Authors:  Haifeng Wang; Lianyu Chen; Yang Liu; Bangzhen Luo; Nanzi Xie; Tao Tan; Lige Song; Pei Erli; Ming Luo
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

Review 7.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

8.  Improved Transplanted Stem Cell Survival in a Polymer Gel Supplemented With Tenascin C Accelerates Healing and Reduces Scarring of Murine Skin Wounds.

Authors:  Cecelia C Yates; Austin Nuschke; Melanie Rodrigues; Diana Whaley; Jason J Dechant; Donald P Taylor; Alan Wells
Journal:  Cell Transplant       Date:  2016-07-22       Impact factor: 4.064

9.  The Effect of Bone-Marrow-Derived Stem Cells and Adipose-Derived Stem Cells on Wound Contraction and Epithelization.

Authors:  Cagri A Uysal; Morikuni Tobita; Hiko Hyakusoku; Hiroshi Mizuno
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-06-01       Impact factor: 4.730

10.  Evidence-based management strategies for treatment of chronic wounds.

Authors:  Frank Werdin; Mayer Tennenhaus; Hans-Eberhardt Schaller; Hans-Oliver Rennekampff
Journal:  Eplasty       Date:  2009-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.